Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Volker Arolt

Showing results (171-180 of 351) with videos related to

Pageof 36
Sort By:
Acta Neuropsychiatrica|September 24, 2020
Brain-derived neurotrophic factor, depressive symptoms and somatic comorbidity in patients with coronary heart diseaseMira Tschorn, Stella Linnea Kuhlmann, Nina Rieckmann, et al.
The International Journal of Neuropsychopharmacology|December 1, 2005
Association of the functional -1019C/G 5-HT1A polymorphism with prefrontal cortex and amygdala activation measured with 3 T fMRI in panic disorderKatharina Domschke, Miriam Braun, Patricia Ohrmann, et al.
Disease Markers|September 11, 2012
KPNA3 variation is associated with schizophrenia, major depression, opiate dependence and alcohol dependenceCharles P Morris, Bernhard T Baune, Katharina Domschke, et al.
Frontiers in Psychiatry|July 30, 2019
Low-Grade Inflammation as a Predictor of Antidepressant and Anti-Inflammatory Therapy Response in MDD Patients: A Systematic Review of the Literature in Combination With an Analysis of Experimental Data Collected in the EU-MOODINFLAME ConsortiumGara Arteaga-Henríquez, Maria S Simon, Bianka Burger, et al.
The International Journal of Neuropsychopharmacology|March 23, 2012
Monoamine oxidase A gene DNA hypomethylation - a risk factor for panic disorder?Katharina Domschke, Nicola Tidow, Henriette Kuithan, et al.
General Hospital Psychiatry|December 12, 2018
Depressive symptoms and health care within 30 days after discharge from a cardiac hospital unitJakob Hornung, Stella Linnea Kuhlmann, Maria Radzimanowski, et al.
Journal of Psychiatry & Neuroscience : JPN|November 23, 2012
Mood-congruent amygdala responses to subliminally presented facial expressions in major depression: associations with anhedoniaAnja Stuhrmann, Katharina Dohm, Harald Kugel, et al.
Human Brain Mapping|September 17, 2013
Amygdala excitability to subliminally presented emotional faces distinguishes unipolar and bipolar depression: an fMRI and pattern classification studyDominik Grotegerd, Anja Stuhrmann, Harald Kugel, et al.
Journal of Psychosomatic Research|July 17, 2004
A brief diagnostic screening instrument for mental disturbances in general medical wardsPer Fink, Eva Ørnbøl, Frits J Huyse, et al.
Biomed Research International|April 24, 2014
Does rTMS alter neurocognitive functioning in patients with panic disorder/agoraphobia? An fNIRS-based investigation of prefrontal activation during a cognitive task and its modulation via sham-controlled rTMSSaskia Deppermann, Nadja Vennewald, Julia Diemer, et al.
Pageof 36

Showing results (171-180 of 351) with videos related to

Sort By:
Pageof 36
Acta Neuropsychiatrica|September 24, 2020
Brain-derived neurotrophic factor, depressive symptoms and somatic comorbidity in patients with coronary heart diseaseMira Tschorn, Stella Linnea Kuhlmann, Nina Rieckmann, et al.
The International Journal of Neuropsychopharmacology|December 1, 2005
Association of the functional -1019C/G 5-HT1A polymorphism with prefrontal cortex and amygdala activation measured with 3 T fMRI in panic disorderKatharina Domschke, Miriam Braun, Patricia Ohrmann, et al.
Disease Markers|September 11, 2012
KPNA3 variation is associated with schizophrenia, major depression, opiate dependence and alcohol dependenceCharles P Morris, Bernhard T Baune, Katharina Domschke, et al.
Frontiers in Psychiatry|July 30, 2019
Low-Grade Inflammation as a Predictor of Antidepressant and Anti-Inflammatory Therapy Response in MDD Patients: A Systematic Review of the Literature in Combination With an Analysis of Experimental Data Collected in the EU-MOODINFLAME ConsortiumGara Arteaga-Henríquez, Maria S Simon, Bianka Burger, et al.
The International Journal of Neuropsychopharmacology|March 23, 2012
Monoamine oxidase A gene DNA hypomethylation - a risk factor for panic disorder?Katharina Domschke, Nicola Tidow, Henriette Kuithan, et al.
General Hospital Psychiatry|December 12, 2018
Depressive symptoms and health care within 30 days after discharge from a cardiac hospital unitJakob Hornung, Stella Linnea Kuhlmann, Maria Radzimanowski, et al.
Journal of Psychiatry & Neuroscience : JPN|November 23, 2012
Mood-congruent amygdala responses to subliminally presented facial expressions in major depression: associations with anhedoniaAnja Stuhrmann, Katharina Dohm, Harald Kugel, et al.
Human Brain Mapping|September 17, 2013
Amygdala excitability to subliminally presented emotional faces distinguishes unipolar and bipolar depression: an fMRI and pattern classification studyDominik Grotegerd, Anja Stuhrmann, Harald Kugel, et al.
Journal of Psychosomatic Research|July 17, 2004
A brief diagnostic screening instrument for mental disturbances in general medical wardsPer Fink, Eva Ørnbøl, Frits J Huyse, et al.
Biomed Research International|April 24, 2014
Does rTMS alter neurocognitive functioning in patients with panic disorder/agoraphobia? An fNIRS-based investigation of prefrontal activation during a cognitive task and its modulation via sham-controlled rTMSSaskia Deppermann, Nadja Vennewald, Julia Diemer, et al.
Pageof 36